Gastrointestinal Endoscopy in Patients on Direct Oral Anticoagulants. A Consensus Paper of the Romanian Society of Gastroenterology and Hepatology

Authors

  • Andreea Farcas Drug Information Research Center, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Simona Bataga Gastroenterology Department, University of Medicine and Pharmacy, Târgu-Mureș
  • Cristina Cijevschi Institute of Gastroenterology and Hepatology, Grigore T. Popa University of Medicine and Pharmacy, Iași
  • Mircea Diculescu Center of Gastroenterology and Hepatology Fundeni, Carol Davila University of Medicine and Pharmacy. Bucharest
  • Daniela Dobru Gastroenterology Department, University of Medicine and Pharmacy, Târgu-Mureș
  • Eugen Dumitru Faculty of Medicine, Ovidius University of Constanța
  • Adrian Goldis Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara
  • Laurentiu Nedelcu Department of Internal Medicine, Transilvania University, Brasov
  • Alina Popescu Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara
  • Ioan Sporea Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara
  • Anca Trifan Institute of Gastroenterology and Hepatology, Grigore T. Popa University of Medicine and Pharmacy, Iași
  • Simona Valean 1st Medical Clinic, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Cristian Gheorghe Center of Gastroenterology and Hepatology Fundeni, Carol Davila University of Medicine and Pharmacy. Bucharest
  • Dan Lucian Dumitrascu 2nd Medical Department Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

DOI:

https://doi.org/10.15403/jgld.2014.1121.272.end

Keywords:

direct oral anticoagulants, endoscopy, therapy management

Abstract

Management of patients undergoing endoscopy and under treatment with the newer direct oral anticoagulants (DOACs) is a common and a complex clinical issue that gastroenterologists have to face more and more often these days. The increasing use of DOACs in patients requiring both short- and long-term anticoagulation is mostly due to the advantages these agents offer, among which the lack of monitoring requirements and the reduced need of dose adjustments are perhaps the most important ones. Managing these patients in the peri-endoscopic period implies balancing the risk for thrombosis that a certain patient carries and the bleeding risk associated with the endoscopic procedure itself. The Romanian Society of Gastroenterology and Hepatology decided to create a consensus paper to serve to practitioners and teachers. After reviewing the available published data and existing recommendations, a Delphi consensus process was carried out involving the leaders of opinion in this field. After reaching expert consensus, we provide herein guidance for a practical approach of DOACs therapy management in patients with endoscopic interventions.

Downloads

Published

2018-06-30

How to Cite

1.
Farcas A, Bataga S, Cijevschi C, Diculescu M, Dobru D, Dumitru E, Goldis A, Nedelcu L, Popescu A, Sporea I, Trifan A, Valean S, Gheorghe C, Dumitrascu DL. Gastrointestinal Endoscopy in Patients on Direct Oral Anticoagulants. A Consensus Paper of the Romanian Society of Gastroenterology and Hepatology. JGLD [Internet]. 2018 Jun. 30 [cited 2026 Jul. 17];27(2):179-87. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/92

Issue

Section

Position paper